Healthy And Confident
Friday, March 11, 2016
Business Briefing: Europe Investigates Safety of Gilead Leukemia Drug
European regulators have started a review into the safety of Gilead Sciences’ leukemia drug Zydelig over concerns about serious adverse events, including deaths.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment